₄S Onishi

Summary for 2004 [at-glance overview of S Onishi work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author S Onishi. According to available data, in 2004 S Onishi published at least 4 articles. This work was completed in collaboration with several authors including Miyamoto, T and Tamura, S. Many other authors have collaborated with S Onishi as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that S Onishi professional interests are focused around "chronic hepatitis type", "endoscopic mucosal resection" and "versus normal controls". These might also be referred to as "rectal tumors", "lower rectum" or "patients chronic". Statistical analysis shows that S Onishi's writing is likely to contains terms "cyp3a5", "nifedipine", "tumors", "patients", "antibody" and "rectum".

Unfortunately, there is not enough information to establish S Onishi affiliation. Luckily, one email address is on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for S Onishi]

Do you know S Onishi who matches the profile above? Click the photo and let us know!

Alternative names (3) [other authors with names similar to S Onishi]

₉₃Onishi, Saburo, ₁₀Onishi, Sachiko, ₈Onishi, Shigeki

Year 2004 Charts [S Onishi frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of S Onishi publication and funding history for the range of years]

Emails (1) [email addresses extracted from S Onishi affiliations]

hidden to prevent spam, click here to reveal

S Onishi Coauthors (15) [all coauthors with the number of joint publications]

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (3) [condensed summary of the S Onishi affiliations, the leading number and the color conveys importance]

₂Department of Endoscopy, Kochi Medical School, Kochi, Japan.
₁Department of Gastroenterology and Hepatology, Kochi Medical School, Kochi 783-8505, Japan.
₁Clinical Evaluation of Medicines and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Japan.

Key Opinion Leader In [S Onishi is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

no keywords assigned

Keywords (26) [keywords assigned to S Onishi articles by PubMed, the leading number and the color conveys importance]

₃Humans | ₃Male | ₂Adult | ₂Female | ₂Colonoscopy | ₂Aged | ₁Nifedipine | ₁Adenoma | ₁Colon | ₁Genotype | ₁Cytochrome P-450 Enzyme System | ₁Indigotindisulfonate Sodium | ₁Rectal Neoplasms | ₁Rectum | ₁Retrospective Studies | ₁Neoplasm Recurrence, Local | ₁Carcinoma | ₁Middle Aged | ₁Neoplasm Invasiveness | ₁Area Under Curve | ₁Intestinal Mucosa | ₁Colonic Polyps | ₁Analysis of Variance | ₁Hyperplasia | ₁Aged, 80 and over | ₁Coloring Agents

S Onishi Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; S Onishi might be a good expert witness on these terms]

₉cyp3a5 | ₈nifedipine | ₈tumors | ₈patients | ₇antibody | ₇rectum | ₆lsts | ₆rectal | ₆hepatitis | ₆endoscopic | ₅lower | ₅chronic | ₅lesions | ₄ii | ₄subjects | ₄healthy | ₄genotype | ₃serum | ₃anti-ca | ₃liver | ₃resection | ₃type | ₃study | ₃mucosal | ₃laterally | ₃significant | ₃diseases | ₃spreading | ₃detected | ₃total | ₂m-i | ₂autoimmune
₆rectal tumors | ₄lower rectum | ₄patients chronic | ₄cyp3a5 genotype | ₄normal controls | ₃chronic hepatitis | ₃laterally spreading | ₃endoscopic mucosal | ₃subjects cyp3a5 | ₃liver diseases | ₃mucosal resection | ₃hepatitis type | ₃nifedipine disposition | ₂prognosis endoscopic | ₂chronic viral | ₂prevalence liver | ₂resection laterally | ₂hepatitis review | ₂antibody carbonic | ₂carbonic anhydrase | ₂viral hepatitis | ₂lesions lower | ₂serum antibody | ₂anhydrase ii | ₂evaluation endoscopic | ₂review prevalence | ₂spreading rectal | ₂anti-ca ii | ₂ii antibody | ₂upper rectum | ₂ii patients | ₂lsts accounted
₃chronic hepatitis type | ₃endoscopic mucosal resection | ₃versus normal controls | ₃nifedipine disposition healthy | ₂antibody carbonic anhydrase | ₂resection laterally spreading | ₂carbonic anhydrase ii | ₂viral hepatitis review | ₂lesions lower rectum | ₂anti-ca ii antibody | ₂prevalence liver diseases | ₂review prevalence liver | ₂laterally spreading rectal | ₂hepatitis review prevalence | ₂chronic viral hepatitis | ₂patients chronic viral | ₂evaluation endoscopic mucosal | ₂mucosal resection laterally | ₂ii patients chronic | ₂serum antibody carbonic | ₂anhydrase ii patients | ₂spreading rectal tumors | ₂cyp3a5 genotype impact | ₂eight subjects cyp3a5 | ₂type significant versus | ₂disposition healthy volunteers | ₂impact nifedipine disposition | ₂patients chronic hepatitis | ₂genotype impact nifedipine | ₂normal controls patients | ₂hepatitis type significant | ₂significant versus normal

Reader's Comments (0) [comments posted by readers of S Onishi profile]